Pfizer Eyeing Dendreon?

Discussion in 'Pfizer' started by Anonymous, Jan 28, 2015 at 9:36 PM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    Thoughts?
    Pacer doc's just out

    update pacer tonight, document #321 page 4 reads...
    "A PwC team has just been approached by a separate client to preform buy side due diligence services including analyses with both financial and operational due diligence in connection with a possible bid to aquire estate assets (the "Transaction Services"). The Transaction Services Team would provide these due dilligence services and have no contact with the Seattle-based PwC team providing the Sox Services"
     

  2. Anonymous

    Anonymous Guest

    Dendreon is bankrupt and worthless..
     
  3. Anonymous

    Anonymous Guest

    Agree. Perfect fit for our portfolio. Will fit right in!
     
  4. Anonymous

    Anonymous Guest

    hear's a thought- how 'bout you do a little work and earn a real live conversation. Unqualified dick weeds bite.
     
  5. Anonymous

    Anonymous Guest

    Currently 400 million by Val.
    Bidding war underway ahead of next week. Heck Peovenge alone racked up 320 million last year and this without even Europe which just launched